Skip to content

To know the effect of Shunti arka Nebulization and shunti varti Dhumapana in Bronchial Asthma.

To evaluate the effect of Shunti Arka Nebulization and Dhumapana in Tamakashwasa w.s.r to Bronchial Asthma - A comparative clinical study

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046253
Enrollment
40
Registered
2022-10-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

None listed

Sponsors

Dr Amrutha D
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Lakshanas of vegakaleena tamakashwasa 2.Signs and symptoms bronchial asthma (mild to moderate condition acc to GINA parameters) 3.20-60 years of age 4.PEF rate: 60-90% 5.Spirometry (FEV): 60-80%

Exclusion criteria

Exclusion criteria: 1.PEFR - 2.Spirometry 3.H/o Cardiac involvement, Cyanosis 4.Any anatomical defect in airway and other complicated Respiratory disorders like TB, Emphysema, Chronic airway limitation � Uncontrolled Diabetes mellitus and Hypertension

Design outcomes

Primary

MeasureTime frame
Relief in the symptoms of vegakaleena tamakashwasa � Shwasa krichrata (difficulty in breathing) � Ghurghuruka (wheezing) � Kasa with kaphastheevana (cough with expectoration) � Nocturnal waking Timepoint: Before treatment - 1st day After treatment - 5th day follow up - 12th day

Secondary

MeasureTime frame
� PEF � Spirometry � Respiratory rate � Pulse rate Timepoint: Before treatment - 1st day After treatment - 5th day follow up - 12th day

Countries

India

Contacts

Public ContactDr Ananta S Desai

Government Ayurvedic Medical College, Bengaluru

anantdesai30@gmail.com9448185896

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026